AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) has announced its participation in the 2024 Wells Fargo Healthcare Conference on Thursday, Sept. 5, 2024 at 9:30 a.m. ET. Peter Griffith, executive vice president and CFO, and Jay Bradner, executive vice president of Research and Development and CSO, will represent Amgen at the event.
The presentation will be webcast live and made available to the public, media, and investors. The webcast can be accessed on Amgen's website (www.amgen.com) under the Investors section. Amgen's Investor Relations Events Calendar provides details on presentation times and webcast links. The webcast will be archived for at least 90 days after the event for later viewing.
Amgen (NASDAQ:AMGN) ha annunciato la sua partecipazione alla Conferenza Sanitaria Wells Fargo 2024 che si terrà giovedì 5 settembre 2024 alle 9:30 a.m. ET. Peter Griffith, vicepresidente esecutivo e CFO, e Jay Bradner, vicepresidente esecutivo della Ricerca e Sviluppo e CSO, rappresenteranno Amgen all'evento.
La presentazione sarà trasmessa in diretta via web e sarà disponibile per il pubblico, i media e gli investitori. La trasmissione web può essere accessibile sul sito web di Amgen (www.amgen.com) nella sezione Investitori. Il Calendario Eventi delle Relazioni con gli Investitori di Amgen fornisce dettagli sui tempi delle presentazioni e sui collegamenti delle trasmissioni. La trasmissione sarà archiviata per almeno 90 giorni dopo l'evento per una visione successiva.
Amgen (NASDAQ:AMGN) ha anunciado su participación en la Conferencia Sanitaria Wells Fargo 2024 el jueves 5 de septiembre de 2024 a las 9:30 a.m. ET. Peter Griffith, vicepresidente ejecutivo y CFO, y Jay Bradner, vicepresidente ejecutivo de Investigación y Desarrollo y CSO, representarán a Amgen en el evento.
La presentación será transmitida en vivo por web y estará disponible para el público, los medios y los inversores. La transmisión se puede acceder en el sito web de Amgen (www.amgen.com) en la sección de Inversores. El Calendario de Eventos de Relaciones con Inversores de Amgen proporciona detalles sobre los horarios de presentación y los enlaces de transmisión. La transmisión será archivada durante al menos 90 días después del evento para su visualización posterior.
암겐 (NASDAQ:AMGN)이 2024 웰스 파고 헬스케어 컨퍼런스에 참석할 것이라고 발표했습니다. 이 행사는 2024년 9월 5일 목요일 오전 9시 30분 ET에 개최됩니다. 피터 그리핏 최고재무책임자(CFO)와 제이 브래드너 최고과학책임자(CSO) 겸 연구 개발 부사장이 이 행사에 참석할 예정입니다.
발표는 웹캐스트로 실시간 방송되며, 대중, 언론 및 투자자에게 공개됩니다. 웹캐스트는 암겐 웹사이트 (www.amgen.com)의 투자자 섹션에서 접근할 수 있습니다. 암겐의 투자자 관계 이벤트 일정에는 발표 시간과 웹캐스트 링크에 대한 세부정보가 제공됩니다. 웹캐스트는 행사 후 최소 90일 동안 아카이브됩니다.
Amgen (NASDAQ:AMGN) a annoncé sa participation à la Conférence Santé Wells Fargo 2024 qui aura lieu le jeudi 5 septembre 2024 à 9h30 ET. Peter Griffith, vice-président exécutif et CFO, ainsi que Jay Bradner, vice-président exécutif de la recherche et du développement et CSO, représenteront Amgen lors de cet événement.
La présentation sera diffusée en direct sur le web et sera accessible au public, aux médias et aux investisseurs. Le webcast peut être consulté sur le site web d'Amgen (www.amgen.com) dans la section Investisseurs. Le calendrier des événements des relations avec les investisseurs d'Amgen fournit des détails sur les horaires de présentation et les liens de diffusion. Le webcast sera archivé pendant au moins 90 jours après l'événement pour une vision ultérieure.
Amgen (NASDAQ:AMGN) hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 angekündigt, die am Donnerstag, den 5. September 2024 um 9:30 Uhr ET stattfinden wird. Peter Griffith, Executive Vice President und CFO, sowie Jay Bradner, Executive Vice President für Forschung und Entwicklung sowie CSO, werden Amgen bei der Veranstaltung vertreten.
Die Präsentation wird live im Web übertragen und für die Öffentlichkeit, Medien und Investoren zugänglich sein. Der Webcast kann auf der Amgen-Website (www.amgen.com) im Bereich Investoren aufgerufen werden. Der Veranstaltungskalender der Investor Relations von Amgen bietet Informationen zu Präsentationszeiten und Webcast-Links. Der Webcast wird mindestens 90 Tage lang archiviert, um später angesehen zu werden.
- None.
- None.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-2024-wells-fargo-healthcare-conference-302234786.html
SOURCE Amgen
FAQ
When is Amgen (AMGN) presenting at the 2024 Wells Fargo Healthcare Conference?
Who will be representing Amgen (AMGN) at the 2024 Wells Fargo Healthcare Conference?
How can I access Amgen's (AMGN) presentation at the 2024 Wells Fargo Healthcare Conference?
Where can I find information about Amgen's (AMGN) upcoming investor events?
